Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide | Patent Application Number 15707508

15707508
Not Appealed
Patent NumberUS 10167291 B2
Publication NumberUS 20180208596 A1
Filled DateSep 18, 2017
Priority DateJul 2, 2015
Inventor/ApplicantsEdwin Aret
Tjeerd Barf
Jerry Evarts
Cecile Krejsa
Tim Ingallinera
Fritz Blatter
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Assignments
Acerta Pharma
Current
Acerta PharmaAstrazeneca
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.